Literature DB >> 19605765

Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Jussara M do Carmo1, Lakshmi S Tallam, John V Roberts, Elizabeth L Brandon, John Biglane, Alexandre A da Silva, John E Hall.   

Abstract

The purpose of this study was to determine the long-term impact of obesity and related metabolic abnormalities in the absence and presence of hypertension on renal injury and salt-sensitivity of blood pressure. Markers of renal injury and blood pressure salt sensitivity were assessed in 52- to 55-wk-old normotensive melanocortin-4 receptor-deficient (MC4R-/-) mice and lean C57BL/6J wild-type (WT) mice and in 22-wk-old MC4R-/- and WT mice made hypertensive by N(G)-nitro-L-arginine methyl ester (L-NAME) in the drinking water for 8 wk. Old MC4R-/- mice were 60% heavier, hyperinsulinemic, and hyperleptinemic but had similar mean arterial pressure (MAP) as WT mice (115 +/- 2 and 117 +/- 2 mmHg) on normal salt diet (0.4% NaCl). A high-salt diet (4.0% NaCl) for 12 days did not raise MAP in obese or lean mice [DeltaMAP: MC4R (-/-) 4 +/- 2 mmHg; WT, 2 +/- 1 mmHg]. Obese MC4R-/- mice had 23% greater glomerular tuft area and moderately increased GFR compared with WT mice. Bowman's space, total glomerular area, mesangial matrix, urinary albumin excretion (UAE), renal TGF-beta and collagen expression were not significantly different between old MC4R-/- and WT mice. Renal lipid content was greater but renal macrophage count was markedly lower in MC4R-/- than WT mice. Mild increases in MAP during L-NAME treatment (approximately 16 mmHg) caused small, but greater, elevations in UAE, renal TGF-beta content, and macrophage infiltration in MC4R-/- compared with WT mice without significant changes in glomerular structure. Thus despite long-term obesity and multiple metabolic abnormalities, MC4R-/- mice have no evidence of renal injury or salt-sensitivity of blood pressure. These observations suggest that elevations in blood pressure may be necessary for obesity and related metabolic abnormalities to cause major renal injury or that MC4R-/- mice are protected from renal injury by mechanisms that are still unclear.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605765      PMCID: PMC2739784          DOI: 10.1152/ajpregu.00187.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  41 in total

1.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

2.  Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen.

Authors:  C K Abrass; D Spicer; G J Raugi
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

3.  Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.

Authors:  B R Dunn; R Zatz; H G Rennke; T W Meyer; S Anderson; B M Brenner
Journal:  J Hypertens Suppl       Date:  1986-12

4.  Insulin resistance, elevated glomerular filtration fraction, and renal injury.

Authors:  D R Dengel; A P Goldberg; R S Mayuga; G M Kairis; M R Weir
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

Review 5.  Hemodynamic theory of progressive renal disease: a 10-year update in brief review.

Authors:  J R Neuringer; B M Brenner
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

6.  The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat.

Authors:  S M Mauer; M W Steffes; S Azar; S K Sandberg; D M Brown
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

7.  Predictors of new-onset kidney disease in a community-based population.

Authors:  Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

8.  Combined renal effects of overweight and hypertension.

Authors:  J Ribstein; G du Cailar; A Mimran
Journal:  Hypertension       Date:  1995-10       Impact factor: 10.190

9.  Renal disease in patients with massive obesity.

Authors:  B L Kasiske; J T Crosson
Journal:  Arch Intern Med       Date:  1986-06

10.  Renal function and hemodynamic study in obese Zucker rats.

Authors:  S K Park; S K Kang
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

View more
  29 in total

1.  Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

2.  Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats.

Authors:  Jussara M do Carmo; Alexandre A da Silva; John S Rushing; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-28       Impact factor: 3.619

3.  Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Nathan J Freeman; Ammar J Alsheik; Ahmad Adi; John E Hall
Journal:  Hypertension       Date:  2015-11-30       Impact factor: 10.190

Review 4.  Mechanisms limiting body growth in mammals.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  Endocr Rev       Date:  2011-03-25       Impact factor: 19.871

Review 5.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

6.  Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

Authors:  Shankar Munusamy; Jussara M do Carmo; Jonathan P Hosler; John E Hall
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

Review 7.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

8.  Central role for melanocortin-4 receptors in offspring hypertension arising from maternal obesity.

Authors:  Anne-Maj S Samuelsson; Amandine Mullier; Nuria Maicas; Nynke R Oosterhuis; Sung Eun Bae; Tatiana V Novoselova; Li F Chan; Joaquim M Pombo; Paul D Taylor; Jaap A Joles; Clive W Coen; Nina Balthasar; Lucilla Poston
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-06       Impact factor: 11.205

9.  Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Authors:  Aaron J Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Rashmi Bisla; Geoffrey A Williamson; Anil K Bidani; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-24

Review 10.  Obesity, metabolic syndrome and diabetic nephropathy.

Authors:  Christine Maric; John E Hall
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.